O Merimsky1, Y Kollender, J Issakov
1Department of Oncology, The Tel-Aviv Sourasky Medical Center, the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. merimsky@zahav.net.il
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Patients with soft tissue sarcoma (STS) have a 7.5% risk of developing a second primary cancer, a rate significantly higher than the general population. This highlights the importance of screening for secondary malignancies during follow-up care.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: